https://scholars.lib.ntu.edu.tw/handle/123456789/551079
標題: | HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed? | 作者: | TUNG-HUNG SU TAI-CHUNG TSENG JIA-HORNG KAO |
公開日期: | 2018 | 出版社: | John Wiley and Sons Inc. | 卷: | 67 | 期: | 4 | 起(迄)頁: | 1634-1635 | 來源出版物: | Hepatology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044319815&doi=10.1002%2fhep.29740&partnerID=40&md5=a88e0c93761b571b5272b3f785177d59 https://scholars.lib.ntu.edu.tw/handle/123456789/551079 |
ISSN: | 0270-9139 | DOI: | 10.1002/hep.29740 | SDG/關鍵字: | circular DNA; covalently closed circular DNA; entecavir; unclassified drug; antivirus agent; alcohol liver disease; antiviral therapy; cancer incidence; cancer patient; cancer risk; chronic hepatitis B; Hepatitis B virus; human; Letter; liver cell; liver cell carcinoma; liver cirrhosis; mortality rate; patient risk; priority journal; treatment duration; vaccination; virus replication; chronic hepatitis B; Hepatitis B virus; liver cell carcinoma; liver tumor; treatment outcome; Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Treatment Outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。